Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 2, 2026European Heart Journal

Advanced imaging techniques such as speckle tracking, CMR, and CT provide insight into subclinical LV impairment and help distinguish different LV phenotypes in hypertensive heart disease.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

LV remodelling is not specific to hypertensive heart disease, requiring advanced imaging to differentiate other causes of hypertrophy, detect subclinical disease, and guide treatment.

Does advanced multimodality imaging improve the detection and phenotyping of hypertensive heart disease?

Design

Review

Authors

MTMarijana TadićCCCesare CuspidiTMThomas H. Marwick

Discussion

Loading...

Member takes

Overview

May identify subclinical LV impairment missed by standard echocardiography; leaves open effects on risk stratification and outcomes.

Structured PICO

Does advanced multimodality imaging improve the detection and phenotyping of hypertensive heart disease?

P
Population
Hypertensive patients
I
Intervention
Advanced multimodality imaging (echocardiography, speckle tracking, CMR, CT)
O
Outcome
Detection of subclinical left ventricular impairment and distinction of different LV phenotypes

Advanced multimodality imaging improves the detection of subclinical hypertensive heart disease and helps differentiate it from other causes of left ventricular hypertrophy.

Cite This Study

Tadić et al. (2022) studied this question.

synapsesocial.com/papers/69f56d259954c85918edcb2dhttps://doi.org/10.1093/eurheartj/ehac393
View Full Paper
Ask AI
Bookmark
Share